Next milestone in Trinity’s build, buy and partner growth strategy further accelerates the firm’s mission and vision to lead transformation in the life sciences industry
Waltham, MA—Global life sciences consulting firm Trinity Partners today announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. The acquisition marks another proof point in Trinity Partners’ overarching growth strategy and builds upon previous successes and momentum including a strengthened leadership team, U.S. and global expansion, and enhanced product offerings.
TGaS Advisors will operate as a wholly-owned division of Trinity Partners and brings to bear more than 15 years of industry experience including work with a majority of the top 50 pharmaceutical companies and a growing number of biotech companies. Under terms of the agreement, Trinity will add TGaS’s unique benchmarking products to its real-world evidence and primary market research capabilities to power its strategic advisory offerings in corporate and product strategy, launch readiness, pricing and market access, and health economics. The joint go-to-market offerings will enhance clients’ ability to deliver life changing innovations to patients around the globe.
“Our clients operate in a highly competitive marketplace. Their success hinges on ensuring they have the best strategic partner with industry expertise, insights, and analytics on their side,” said David Fitzhenry, CEO & Managing Partner, Trinity Partners. “There is immediate benefit to our clients as we bring TGaS Advisors into the Trinity family and realize our combined potential. We look forward to expanding on their proven track record, built-in network and benchmarking capabilities and including them into our commercialization offerings.”
“Joining forces with Trinity Partners will undeniably make us a better and stronger collective entity not only for our clients and prospects, but also for our employees,” said Gary McWalters, President, TGaS Advisors. “I look forward to this next chapter as it is the perfect long-term scenario to accelerate investment in building our additional benchmarking offerings, delivering our vendor insights to the market and combining those core competencies with a strong Trinity portfolio that will improve the value proposition for our clients.”
“Moving forward, we will continue to target companies across new geographies to expand our influence, accelerate expansion, identify strategic adjacencies that expand collective influence and acquire outside talent and technology to offer new services to clients,” added Fitzhenry.
About TGaS Advisors
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of more than 100 companies, including large, mid-tier, emerging and precommercial life sciences companies, TGaS provides robust comparative intelligence and collaborative network membership services. The team includes more than 50 experienced professionals, most with senior-level experience in the life sciences and related industries.
About Trinity Partners
Trinity Partners is a trusted life sciences strategy consulting firm that takes a personalized approach to working with pharmaceutical, biotech, medical device, and diagnostic clients worldwide to create tailored, evidence-based solutions that drive business strategy and impact bottom lines. Trinity is partnered with Parthenon Capital Partners, a leading, growth-oriented private equity firm. To learn more about Trinity Partners, click here.
For Trinity Partners
Danielle Kirsch, 617-502-4372